Melanoma cases in 8MM to reach 263,000 by 2035

Australia reported the highest incidence rates.

Diagnosed incident melanoma cases across the eight major markets (8MM) are projected to increase from 229,000 in 2025 to 263,000 in 2035.

According to GlobalData's latest Melanoma: Epidemiology Report and Forecast, the United States is projected to record the highest number of diagnosed incident melanoma cases, with more than 130,000 cases by 2035. Canada is expected to report around 14,000 cases, Australia approximately 21,000, and the five major European markets (5EU) about 88,000 cases over the same period.

The report identifies ultraviolet (UV) radiation as a major risk factor for melanoma and notes that Australia has significantly higher incidence rates than other markets.

“The discrepancy between incidence rates of melanoma in Australia and those in all other markets may be explained by a combination of its location on the southern hemisphere, its proximity to the equator, and a considerable number of its population with fair skin,” said Robyn Jones, epidemiologist at GlobalData.

The report also said that Stage 1 accounted for the largest share of diagnosed incident melanoma cases across all eight markets, although proportions varied by country.

Jones said the high rate of early-stage diagnoses reflects growing public awareness of melanoma and the risks associated with UV exposure. ”These are likely attributed to public health protection efforts aimed at increasing awareness of how melanoma presents, alongside multi-pronged interventions to curb UV exposure.”

The eight major markets (8MM) comprise the US, France, Germany, Italy, Spain, the UK, Canada, and Australia. The five major European markets (5EU) comprise France, Germany, Italy, Spain, and the UK.